Investors might want to bet on Mind Medicine (MindMed) Inc. (MNMD), as it has been recently upgraded to a Zacks Rank #2 (Buy). This upgrade is essentially a reflection of an upward trend in earnings ...
This is an edited transcript of an episode of “The Ezra Klein Show.” You can listen to the conversation by following or subscribing to the show on the NYT Audio app, Apple, Spotify, Amazon Music, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback